Overview
Louise Dembry is an Infectious Disease provider in New Haven, Connecticut. Dr. Dembry has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Asymptomatic Bacteriuria and Methicillin-Resistant Staphylococcus Aureus (MRSA).
Her clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Methicillin-Resistant Staphylococcus Aureus (MRSA).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Trustees Of Columbia University In The City Of New York
Anne-catrin Uhlemann is an Infectious Disease provider in New York, New York. Dr. Uhlemann is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Severe Acute Respiratory Syndrome (SARS).
Paul Planet is a Pediatric Infectious Disease specialist and an Infectious Disease provider in New York, New York. Dr. Planet is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Neonatal Sepsis, Sepsis, and Malaria.
Yale University
Rupak Datta is an Infectious Disease provider in New Haven, Connecticut. Dr. Datta is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Asymptomatic Bacteriuria, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and COVID-19.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Asymptomatic BacteriuriaDr. Dembry isAdvanced. Learn about Asymptomatic Bacteriuria.
- Experienced
- Methicillin-Resistant Staphylococcus Aureus (MRSA)